Literature DB >> 26309679

High prevalence of hepatitis B virus infection in primary central nervous system lymphoma.

Yan Meng1, Shengli He2, Qin Liu3, Dongwen Xu3, Tao Zhang3, Zi Chen4.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare extranodal form of non-Hodgkin lymphoma (NHL). The present study aimed to investigate the potential association between infection with the Hepatitis B virus (HBV) and PCNSL. The prevalence of HBV infection in 199 patients with PCNSL was compared in our hospital with that of an age-and sex-matched group of patients with other cancers (except liver cancer), and with a national population-based control group. Enzyme-linked immunosorbent assays were used to test blood samples for HBV markers. It was found that the prevalence of HBV infection in PCNSL was 16.1%, which was higher as compared with patients with other non-hematologic cancers and the national population-based control group. In conclusion, the present study demonstrated that PCNSL patients had a higher prevalence of HBV infection and suggested a potential association between infection with HBV and PCNSL.

Entities:  

Keywords:  Primary central nervous system lymphoma; hepatitis B virus infection; non-Hodgkin lymphoma

Year:  2015        PMID: 26309679      PMCID: PMC4538046     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  Primary CNS lymphoma.

Authors:  Andrés J M Ferreri; Emerenziana Marturano
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-05       Impact factor: 3.020

2.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

3.  Detection of hepatitis B virus DNA in mononuclear blood cells.

Authors:  P Pontisso; M C Poon; P Tiollais; C Brechot
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

4.  Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.

Authors:  Nikolaus Becker; Paul Schnitzler; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Yolanda Benavente; Pierluigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-06       Impact factor: 4.553

5.  HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China.

Authors:  Zheng Wei; Shanhua Zou; Feng Li; Zhixiang Cheng; Junmin Li; Jianmin Wang; Chun Wang; Fangyuan Chen; Junning Cao; Yunfeng Cheng
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

6.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].

Authors:  Wei-Ping Liu; Wen Zheng; Xiao-Pei Wang; Yu-Qin Song; Yan Xie; Mei-Feng Tu; Ning-Jing Lin; Ling-Yan Ping; Zhi-Tao Ying; Li-Juan Deng; Chen Zhang; Jun Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2011-08

Review 8.  Progress in central nervous system lymphomas.

Authors:  Chia-Ching Wang; Julia Carnevale; James L Rubenstein
Journal:  Br J Haematol       Date:  2014-05-16       Impact factor: 6.998

9.  The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.

Authors:  Soon-Thye Lim; Gao Fei; Richard Quek; Lay-Cheng Lim; Lai-Heng Lee; Swee-Peng Yap; Susan Loong; Miriam Tao
Journal:  Eur J Haematol       Date:  2007-08       Impact factor: 2.997

10.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

View more
  3 in total

1.  SLE and Non-Hodgkin's Lymphoma: A Case Series and Review of the Literature.

Authors:  Prajwal Boddu; Abdul S Mohammed; Chandrahasa Annem; Winston Sequeira
Journal:  Case Rep Rheumatol       Date:  2017-03-27

2.  Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization.

Authors:  Grécia C Pessoni; Tássia A Marinho; Megmar M Santos Carneiro; Regina M Martins; Caroline C Soares; Leandro N Silva; Marcia A Matos; Adriano M Arantes; Juliana A Teles; Nathalia C Santos; Sheila Araujo Teles
Journal:  Hematol Transfus Cell Ther       Date:  2019-03-28

3.  Primary Central Nervous System T-cell Lymphoma Associated With Hepatitis B and D Virus Coinfection.

Authors:  Saqib R Khan; Saad Nasir; Muhammad Tariq; Zoya A Siddiqui; Munira Moosajee
Journal:  Cureus       Date:  2021-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.